Statin Use is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer:a Nested Case-Control Analysis

Alexandre, Leo, Clark, Allan B, Bhutta, Hina Y, Holt, Sean, Lewis, Michael Pn and Hart, Andrew R (2014) Statin Use is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer:a Nested Case-Control Analysis. Gastroenterology, 146 (3). 661–668. ISSN 0016-5085

[img] Microsoft Word (acceptance e-mail) - Submitted Version
Download (16kB)

Abstract

Most patients with esophageal adenocarcinoma (EAC) or squamous cell cancer (ESCC) present with advanced, incurable disease. Statins have reported anti-carcinogenic effects and may be chemoprotective. We investigated the association between regular use of statins and the main histologic subtypes of esophageal malignancy (EAC, esophagogastric junctional adenocarcinoma [EGJA], and ESCC) in the UK general population.

Item Type: Article
Additional Information: Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Uncontrolled Keywords: esophageal cancer,statins,aetiology
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 20 Jan 2014 15:54
Last Modified: 21 Apr 2020 22:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/46092
DOI: 10.1053/j.gastro.2013.11.046

Actions (login required)

View Item View Item